Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
Introduction Minority populations in the USA are disproportionately affected by cardiovascular conditions. Reduced responsiveness to clopidogrel among carriers of CYP2C19 variants has been reported in patients with either coronary artery disease (CAD) or acute coronary syndrome (ACS) after the percu...
Main Authors: | Dagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, Hector J Nunez, Ariel F Gonzalez, Lorena Gonzalez-Sepulveda, Sona Rivas-Tumanyan, Hetanshi Naik, Gualberto Ruaño, Stuart A Scott, Jorge Duconge |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-08-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/8/e038936.full |
Similar Items
-
A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.
by: Jorge Duconge, et al.
Published: (2016-01-01) -
Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
by: Abiel Roche-Lima, et al.
Published: (2020-01-01) -
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
by: Hernandez-Suarez DF, et al.
Published: (2018-06-01) -
Pharmacogenetics of Antiplatelet Drugs
by: Ronan Curtin, et al.
Published: (2002-01-01) -
Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration.
by: Toshiaki Toyota, et al.
Published: (2017-01-01)